Meng Q, Sun H* and Liu J*. Precise somatic genome editing for treatment of inborn errors of immunity. Front Immunol, Accepted. Zhang G†, Liu Y†, Huang S†, Qu S, Cheng D, Yao Y, Ji Q, Wang X*, Huang X* and Liu J*. Enhancement of prime editing via xrRNA motif-joined pegRNA. Nat Commun 2022, 13(1):1856. Wang Y†, Zhang G†, Meng Q†, Huang S, Guo P, Leng Q, Liu G*, Huang X* and Liu J*. Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors. Nat Commun 2022, 13(1):1454. Meng Q†, Yang H†, Zhang G, Ma P, Liu X, Dang L, Li G, Huang X, Wang X*, Liu J* and Leng Q*. CRISPR/Cas12a-assisted rapid identification of beer spoilage bacteria. Innov Food Sci Emerg Technol 2021, 74：102854. Gup P†, Yang L†, Zhang M, Zhang Y, Tong Y, Cao Y and Liu J*. A monocyte-orchestrated IFN-I-to-IL-4 cytokine axis instigates pro-tumoral macrophages and thwarts poly(I:C) therapy. J Immunol 2021, 207:408-420. Tong Y†, Zhou L†, Yang L, Cao Y, Qin FX and Liu J*. Concomitant Type I IFN and M-CSF signaling reprograms monocyte differentiation to drive pro-tumoral arginase production. EBioMedicine 2019, 39:132-44.
|
